Contineum Therapeutics (CTNM) Earnings Date & Reports

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CTNM is expected to report earnings to rise 12.82% to -43 cents per share on August 18

Contineum Therapeutics CTNM Stock Earnings Reports

Q2'26

Est.

$-0.44

Q1'26

Beat

by $0.46

Q4'25

Beat

by $0.16

Q3'25

Beat

by $0.15

Q2'25

Missed

by $0.34

The last earnings report on May 05 showed earnings per share of -38 cents, beating the estimate of -85 cents. With 132.88K shares outstanding, the current market capitalization sits at 432.93M.

View a ticker or compare two or three

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+18%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CTNM

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement